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Abstract
The mechanism of the previously reported antidiabetic effect of Basella alba is unknown. This study investigated
the role of B. alba aqueous leaf extract in the modulation of inflammatory cytokines and islet morphology in
streptozotocin-induced diabetic rats. Forty male Wistar rats, between 8 and 10 weeks old, were randomly divided
into four groups (n = 10) and administered the following treatments: Healthy control (H-c) and Diabetic control
(D-c) animals received normal saline 0.5 mL/100 g body weight daily, while Healthy Treatment (H-Ba) and Dia-
betic Treatment (D-Ba) rats received the plant extract 200 mg/kg body weight daily. All treatments were adminis-
tered by oral gavage. Diabetes was induced in D-c and D-Ba rats by a single intraperitoneal injection of
streptozotocin (55 mg/kg body). The body weight and fasting blood sugar (FBS) levels were recorded every week
for 4 weeks, after which the rats were euthanized and samples collected for further analysis. After the experiment,
FBS level was significantly reduced (p < 0.0001) in rats in the D-Ba group, but increased (p < 0.001) in rats in the
D-c group. The absolute (H-c and H-Ba vs D-c, p < 0.05) and relative (D-Ba vs H-c, p < 0.05; D-Ba vs H-Ba,
p < 0.005) weights of the pancreases were significantly higher after the experiment. The rats in the D-c group had
significantly higher levels of serum interleukin-1β (p < 0.001 vs H-c; p < 0.05 vs H-Ba and D-Ba) and monocyte
chemotactic protein-1 (p < 0.0001), but lower levels of interleukin-10 (p < 0.05) in comparison with the other
groups. Histopathological examination revealed severe interstitial congestion, reduced islet area (p < 0.0001), and
increased islet cell density in the D-c group compared with those in the D-Ba group. From these findings, it was
concluded that the aqueous extract of B. alba stimulates the recovery of beta-islet morphology in streptozotocin-
induced diabetic rats by modulating the peripheral production of inflammatory cytokines.
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INTRODUCTION
Cytokines are members of a large group of polypep-
tides that mediate inflammatory and immune responses in
tissues and play a central role in the pathophysiology of
most chronic diseases, including diabetes mellitus (DM)
(1). They can be classified into pro- and anti-inflamma-
tory cytokines, with the process of inflammation believed
to be a result of interplay between these two groups (2).
However, more recent views on the role of cytokines in
inflammation suggest that such a classification may not be
all-encompassing, with certain cytokines capable of both
activities (2). Conventionally, cytokines such as interleu-
kin-1 (IL-1), IL-12, IL-18, interferon-gamma (IFN-γ), tumor
necrosis factor, and granulocyte-macrophage colony stimu-
lating factor are considered pro-inflammatory, whereas IL-
4, IL-10, IL-13, transforming growth factor-β, and IFN-α
are anti-inflammatory (2). Chemokines, such as monocyte
chemotactic protein-1 (MCP-1), are closely associated
with cytokines and important in the inflammatory pro-
cesses. During the progression of type 1 diabetes mellitus
(T1DM), pro-inflammatory cytokines invade the islet cells
of the pancreas and exert cytotoxic effects on beta cells
(3). Therefore, T1DM is essentially an inflammatory dis-
ease of the endocrine pancreas, which destroys insulin-
producing beta islet cells via a cytokine-mediated autoim-
mune reaction (4). It is challenging to understand the spe-
cific role played by inflammatory cytokines in the
pathophysiology of DM, owing to the complex physiologi-
cal functions of cytokines and their inhibitors. However,
ever-changing dynamics exist between the pro- and anti-
inflammatory components of the immune system, but in
immune mediated diseases such as T1DM, the anti-
inflammatory mediators appear to provide insufficient
protection against the pro-inflammatory activity (5).
The destruction of insulin-producing islet beta-cells of
the pancreas results in insulin deficiency and consequently
hyperglycemia, which is the primary anomaly in insulin-
dependent DM. The circulating levels of the most pro-
inflammatory cytokines are usually elevated in DM, largely
as a result of hyperglycemia, which stimulate blood levels
of cytokines to increase via an oxidative mechanism (6,7).
Hyperglycemia also results in hyperosmolality of the
extracellular fluid, a physiological state that enhances the
production of cytokines by mononuclear cells in periph-
eral circulation (8). Otto and colleagues (8) suggested that
hy- perglycemia causes tissue inflammation through the
stimulation of cytokine production via osmotic stress.
Streptozotocin and alloxan are two diabetogenic agents
commonly used to induce experimental DM in laboratory
animals through their ability to generate reactive oxygen
species via different routes, and subsequently induce cyto-
toxic effects on the beta-cells of the pancreas (9). Strepto-
zotocin is a methylating agent that causes extensive beta-
cell necrosis in rodents after the injection of a single high
dose. Multiple low doses induce partial beta-cell apopto-
sis, which triggers an autoimmune reaction that eventu-
ally eliminates the remaining cells (10). It was originally
used as an alkylating agent for the treatment of metastatic
tumors of islet cells, but was later discovered to be diabe-
togenic by Rakieten et al. in 1963 (11) and has since become
a chemical agent of choice for experimental induction of
DM (12).
Diabetes continues to pose a serious threat to human
survival and constitutes a major health challenge world-
wide despite the treatments currently available. Recent
studies reported an 8.3% prevalence rate, with 387 mil-
lion people affected by the disease worldwide and an esti-
mated 46.3% cases still undiagnosed (13), with the majority
of these cases in underdeveloped and developing coun-
tries where the resources for disease management are
scarce. Therefore, there is a need for the continued investi-
gation of new treatments for this disease.
Basella alba (Ba), a leafy green vegetable, belongs to
the family Basellaceae and is said to be native to South
Asia, but is also widely cultivated in tropical Africa. The
common names of this perennial vine, which differ in geo-
graphical locations, include Ceylon spinach, Malabar spin-
ach, and Saan choy. The plant has a deep green stem with
thick and fleshy oval shaped leaves arranged throughout
the length of the creeping stem. It is often mistaken for a
counterpart in the Basellaceae family, Basella rubra, which
has a pinkish or purple stem with pink colored veins run-
ning through the leaves (14). Ba has been reported to
lower blood sugar levels and improve the health of dia-
betic rats when administered orally as an aqueous extract
(15). However, as the mechanism by which Ba exerts its
antidiabetic actions is relatively unknown, this is the focus
of our present study. This research aimed to investigate
modulation of cytokine levels in the serum and stimula-
tion of beta-islet cell regeneration as the possible antidia-
betic mechanisms of Ba.
MATERIALS AND METHODS
Preparation of plant extract. The research plant, Ba,
was sourced fresh from Osun state in south western Nige-
ria, identified, and authenticated by the Department of
Botany, University of Ibadan, Nigeria (voucher number:
UIH-22391). The leaves were then washed and dried at
room temperature to preserve heat-labile components. The
dried leaves were subsequently ground to a powder and
100 g was extracted in 1,000 mL distilled water in accor-
dance with the method described by Iloki-Assanga et al
(16). The liquid extract was filtered through muslin cloth
and the filtrate was freeze-dried for 24 hr to obtain a pow-
dery extract that was subsequently dissolved in normal
saline. This formed the stock solution that was adminis-
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tered to the rats by oral gavage during the course of the
study.
Animal care and ethical considerations. Male Wistar
rats were obtained from Stellenbosch University animal
house and acclimatized in the animal experimental labora-
tory of the Faculty of Medicine and Health Sciences, Stel-
lenbosch University, Tygerberg, South Africa. The animals
were given free access to food (standard rat chow) and
water, with the exception of a period of overnight fasting
prior to the collection of blood for fasting blood sugar
(FBS) measurement. The rats were housed under standard
atmospheric conditions and the animals were exposed to a
12-hr light/dark cycle. All experiments complied with the
National Institutes of Health Guidelines (National Insti-
tutes of Health Publication No. 80-23, revised 1978) for
the handling of laboratory animals. The Health and Well-
ness Sciences Research Ethics Committee (HWS-REC) of
Cape Peninsula University of Technology, Cape Town,
South Africa, granted ethical approval for this study (ref-
erence number: CPUT/HWS-REC 2015/A04).
Study design. Forty male Wistar rats, between 8 and
10 weeks old, were randomly divided into four groups
(n = 10) and administered the following treatments via
oral gavage: animals in the healthy control (H-c) and dia-
betic control (D-c) groups received normal saline at
0.5 mL/100 g body weight daily; animals in the healthy
treatment (H-Ba) and diabetic treatment (D-Ba) groups
received the plant extract at 200 mg/kg body weight daily.
Induction of DM. The rats from the D-c and D-Ba
groups were administered a single intraperitoneal injec-
tion of streptozotocin (55 mg/kg) after an overnight fast.
Prior to administration, streptozotocin was freshly dis-
solved in ice-cold citrate buffer (0.1 M), pH 4.5. The ani-
mals were subsequently permitted food and water and
FBS was measured after 72 hr to confirm diabetes. The
rats with an FBS value greater than 11.1 mmol/L (200 mg/
dL) were considered diabetic (17) and included in the study.
Measurement of FBS and weight. The FBS and
body weight were recorded weekly in all animals from the
four experimental groups. The blood samples for FBS
were collected from the tail capillaries by pricking the tip
of the tail with a sterile lancet and expressing one or two
drops of blood. This was applied in the appropriate man-
ner to a glucometer (ONETOUCH® Ultra2) strip to deter-
mine the FBS levels. The rat weight was recorded using a
portable electronic balance.
Pancreas and blood sample collection. All animals
were euthanized via exsanguination with a high dose (100
mg/kg) of intraperitoneal sodium pentobarbital after a 4-
week treatment. The blood was collected via cardiac punc-
ture into serum clotting activator tubes (VACUETTE®),
centrifuged at 4,000 g for 10 min at 4oC, and the serum
was removed and stored at −80oC for the assessment of
serum cytokine levels. The pancreas was carefully removed,
washed, and weighed and then preserved in formalin for
histological studies. The relative weight of the pancreas
was calculated from the division of the pancreas weight by
the animal’s total body weight.
Assessment of serum cytokines. The evaluation of
the various cytokine levels was performed on triplicate
serum samples by using multiplex technology. The sam-
ples were removed from −80oC and allowed to thaw at
room temperature prior to the assay. The analysis of cyto-
kine levels was achieved by using the Bio-Plex ProTM
Reagent kit in 1 × 96-well flat-bottomed plate, Cat. #171-
304070M (USA). The assays were performed in accor-
dance with the product protocol manual (Merck Milli-
pore, Billerica, MA, USA) and the Bio-Plex platform
(Bio-Rad Laboratories, Hercules, CA, USA) was used to
read the plate.
Histopathological analysis of the pancreas. Pancrease
tissue samples from each rat were dissected, weighed, and
immediately fixed in 10% buffered formalin. The tissues
were processed by embedding in paraffin wax and sec-
tioned at 4~6 μm thickness before staining with hematox-
ylin and eosin (H&E stain). The prepared slides were
examined microscopically by using a Digital Microscope,
VJ-2005 DN model Bio-microscope® (WanTong Preci-
sion Instruments Co., Ltd., China).
Determination of islet cell area and density. The
morphometric analysis was conducted using TS View CX
Image® Software (version 6.2.4.3) and Motic Image 2000
(Motic China Group Co., Ltd., Xiamen, China). For each
slide, the islet parenchyma were observed and several
images were captured at ×400 magnification. Discreet ran-
dom islet areas were determined using (Motic China
Group Co., Ltd.). The number of viable cells in each area
was analyzed. The summation of all islet areas per slide
was calculated to estimate the total area and, likewise, the
summation of cell count values yielded the total cell count
per slide; the total islet density was determined in each
slide from the formula: Total cell count/Total area of count.
Statistical analysis. GraphPad Prism version 5.0 was
used to analyze all the data. The values were expressed as
the mean ± SEM and the differences between the means
of each group were determined by one-way analysis of
variance (ANOVA). The Bonferroni post-test was applied
and values of p < 0.05 were considered to indicate statisti-
cal significance.
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Ba group compared with that in the H-Ba group, the
weight of pancreas was not significantly different between
the two groups. The relative weight of the pancreas was
significantly higher in rats in the D-Ba  group when com-
pared with that in rats in both the H-c (p < 0.05) and H-Ba
(p < 0.005) groups. There was no significant difference
between the relative pancreatic weights of rats in the D-c
group and of the other three groups (Fig. 1).
Effect of treatments on serum cytokine levels. The
serum levels of IL-1β were significantly higher in sam-
ples from the D-c group compared with those in samples
from all other groups (p < 0.001 v s H-c and p < 0.05 vs
H-Ba and D-Ba). Similarly, samples from the D-c group
had significantly (p < 0.0001) higher levels of MCP-1
compared with those from the other three groups (Fig. 2).
The serum levels of IL-4 and IL-13 were not differ signifi-
cantly among any of the four experimental groups. How-
ever, IL-10 level was significantly lower (p < 0.05) in the
samples from the D-c when compared with those in the
other groups. Furthermore, the serum IL-10 levels in H-c
samples were significantly higher (p < 0.05) than the lev-
els in samples from the D-Ba group (Fig. 3).
RESULTS
Effect of treatments on FBS levels. After a single
intraperitoneal injection of streptozotocin in D-c and D-Ba
rats, the FBS levels in both groups before the commence-
ment of treatments were significantly higher than those in
FBS in H-c and H-Ba rats (p < 0.0001). After a 4-week
treatment period, the FBS levels were not significantly
different in the rats in the H-c and H-Ba groups. The FBS
level in the D-c rats was significantly increased (p < 0.001),
but was significantly reduced in D-Ba rats (p < 0.0001)
compared with readings recorded in the respective groups
prior to the start of treatment (Table 1).
Effect of treatments on body weight, pancreas
weight, and relative pancreas weight. After the 4-
week treatment period, the body weight and weight of the
pancreas were significantly (p < 0.05) lower in the two
diabetic groups (D-c + D-Ba) compared with those in the
healthy control rats. There were no significant differences
in both body and pancreas weights between the two dia-
betic groups and the two control groups of rats. Although
body weight was significantly (p < 0.05) lower in the D-
Table 1. Fasting blood sugar before commencement and after completion of four weeks of Basella alba treatment, Islet cell area
and Islet cell density of Control and Treatment rats
Groups
Fasting blood sugar
(mmol/L) Islet cell area
(× 105 Sqµm)
Islet cell density
(× 10−2 Cells/Sqµm) 
Before treatment After treatment
Healthy control (H-c) 04.48 ± 0.15 04.46 ± 0.14ns  2.54 ± 0.36c  0.009 ± 0.00#




 0.03 ± 0.00
*
 1.468 ± 0.23
*
Healthy treatment (H-Ba) 04.51 ± 0.15 04.48 ± 0.15
ns
 6.20 ± 0.31
*#
 0.009 ± 0.00
#
Diabetic treatment (D-Ba) 17.74 ± 1.34* 10.71 ± 0.41b  2.68 ± 0.45#  0.012 ± 0.00#
Values are expressed as mean ± SEM, FBS readings before commencement of treatment in all groups were compared with that of H-c
and readings before and after four weeks of treatment were compared in each group. Islet cell area and density in all experimental
groups were compared with control groups.
The p values were denoted as; nsNot significant, ap < 0.001, bp < 0.0001 vs. values before treatment.
*p < 0.0001 vs. H-c, #p < 0.0001 vs. D-c.
mmol/L = Millimoles per litre, Sqμm = Square micrometres.
Fig. 1. Body weight (A), weight of pancreas (B) and relative weight of pancreas (C) of rats after 4 weeks of Basella alba treatment.
*p < 0.05, **p < 0.005.
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Effect of treatments on pancreatic histology. The
histopathological analysis of the pancreas showed nor-
mal interstitial architecture and islet sections in slides
from the H-c, H-Ba, and D-Ba groups; however, the islet
sections in the H-c group appeared to be slightly larger
in slides from the H-c group compared with those in the
other groups. Severe interstitial congestion and reduced
islet sections were observed in samples from the D-c
group, in which the rats did not receive the plant extract
(Fig. 4).
Effect of treatments on area and density of islet cell.
As shown in the table, the islet cell area was significantly
reduced in the D-c group when compared with those in the
other three groups (p < 0.0001), whereas it was increased
in the H-Ba group compared with those in the other
groups (p < 0.0001). Conversely, the islet cell density was
significantly lower in the H-c, H-Ba, and D-Ba rats (p <
0.0001) compared with that in the D-c group. There was
no significant difference in the islet cell density among the
rats in the H-c, H-Ba, and D-Ba groups.
DISCUSSION
The reduction in the FBS levels observed in the dia-
betic rats treated with aqueous Ba extract (D-Ba) con-
Fig. 3. Levels of the anti-inflammatory cytokines IL-4 (A), IL-10 (B) and IL-13 (C) in the sera of rats after 4 weeks of Basella alba
treatment [ns = Not significantly different]. *p < 0.05.
Fig. 4. Histopathological photomicrographs of the pancreas
(H & E) showing slides from: (A) Healthy control rat with nor-
mal interstitium and islet section; (B) Diabetic control rat with
reduced islet section (Long arrow) and severe interstitial con-
gestion (Short arrow); (C) Healthy treatment rat with normal
interstitium and islet section; and (D) Diabetic treatment rat
with normal interstitium and islet section.
Fig. 2. Levels of a pro-inflammatory cytokine, IL-1β (A) and a chemokine, MCP-1 (B), in the sera of rats after 4 weeks of Basella alba
treatment. *p < 0.05, **p < 0.001, ***p < 0.0001.
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firmed the previously reported anti-hyperglycemic effect
of the plant (15). Furthermore, levels of potent mediators
of inflammation, such as IL-1β (18) and MCP-1, were
considerably lower in the serum samples of the treated
diabetic rats compared with those in the sera of their
untreated counterparts, which alluded to the possibility of
a correlation between the antihyperglycemic (15) and anti-
inflammatory (19,20) effects of Ba. As mentioned in the
introduction part, hyperglycemia stimulates the peripheral
production of inflammatory cytokines via oxidative (6,7)
and osmotic stress (8) mechanisms. These inflammatory
mediators play a major role in the suppression of beta-islet
cell function and ultimately in the induction of apoptosis
of the cells by initiating and intensifying immune assaults
(21). This implies that an unpleasant interplay exists
between the high serum levels of inflammatory mediators
and hyperglycemia in a vicious cycle that culminates in
deterioration of the symptoms of T1DM. The prevention
of one or all of the following occurrences (hyperglyce-
mia, production of pro-inflammatory cytokines/chemok-
ines, or the depletion of anti-inflammatory cytokines)
is therefore expected to exert a positive impact on beta-
islet cell function and survival in ongoing T1DM. In the
present study, T1DM was induced by a single intraperito-
neal injection of a high dose of streptozotocin (55 mg/kg)
to sufficiently ablate the insulin production of beta-islet
cells of the pancreas (22). We observed that the reduced
levels of blood sugar and proinflammatory cytokines,
but the higher IL-10 levels and the enhanced level of
IL-10 in the blood serum from diabetic animals treated
with the aqueous extract of Ba (i.e., D-Ba group). These
clearly highlight the actions underlying the anti-inflamma-
tory role of Ba. Gomphrenin I (15S-betanidin 6-O-β-glu-
coside), the principal coloring agent in Ba fruit, was found
to be a potent antioxidant and inhibitor of inflammation
(23). It was observed to inhibit the transcription and
expression of genes encoding certain inflammatory cyto-
kines, including IL-1β (23). Although Gomphrenin I was
not isolated during the phytochemical analysis of aqueous
leaf extract of Ba in a previous study (24), the possibility
of its presence in the leaves cannot be excluded in light of
the observations from this study. Furthermore, the estab-
lished chemical constituents of the leaf extract, such as
tannins, flavonoids, mucilage, and saponin (19), have
strong antioxidant properties (25,26) which may also
explain the ability of the extract to suppress the produc-
tion of inflammatory cytokines. This is because the gener-
ation of oxygen free radicals is known to contribute
significantly to the initiation and progression of systemic,
as well as localized inflammatory responses, via the acti-
vation of nuclear factors that stimulate release of cyto-
kines (27).
The histopathological findings in this study are also
noteworthy. A recovery of previously lost islet regions in
the pancreas of diabetic rats that were treated with the
plant extract appears to have occurred, as evidence by the
significantly larger islet area in comparison with the pan-
creas sections from their untreated counterparts. Addition-
ally, even though body weight was significantly lost in
both diabetic groups, the relative pancreatic weight loss
was lower in the diabetic rats treated with Ba extract,
which suggested a protective role for the plant with regard
to the degenerative damage of the pancreas. From the pres-
ent data, we were unable to ascertain whether the larger
islet area in the treated rats occurred as a result of regener-
ation of new beta-islet cells or from the inhibition of prog-
ress of streptozotocin-induced apoptosis, but this topic
should be explored for further research. It is also not exactly
clear why a huge increase in islet area was observed in the
healthy treatment group (H-Ba). This may be a partial
result of the unchallenged action of Ba in the stimulation
of islet cell proliferation. Presently, the curative therapies
of T1DM are based on the restoration of endogenous insu-
lin production either by the transplantation of beta-islet
cells or the whole pancreas with concurrent immunosup-
pression (28,29). This has its own disadvantages, espe-
cially those that stem from the continuous need to suppress
the immune system and the increased risk of vascular and
metabolic complications (29). The ability to restart insulin
synthesis using a natural medicinal agent that is capable of
restoring islet function well enough to achieve better glu-
cose homeostasis in T1DM would therefore be extremely
valuable. Interestingly, islet cell density was observed to
be highest in the diabetic control (D-c) rats that were not
treated with the extract. This can be explained by the
increases in the alpha-islet and delta-islet cell mass that
usually occur after a selective streptozotocin-induced
destruction of the insulin-producing beta-islet cells (30).
The inflammatory milieu in the streptozotocin-induced
model of T1DM actually allows for the alpha- and delta-
cells to expand and proliferate at a faster rate than usual
(30) to compensate for the lost beta-cells. There is also a
marked increase in beta-islet cell proliferation during the
early stages of T1DM in humans (31), which may also be
a contributory factor to the extremely high islet cell den-
sity observed in the control diabetic rats. Further studies in
this respect may include differential staining of the vari-
ous islet cell types to specifically account for the composi-
tion of the islet population and the quantitative analysis of
serum insulin and the other hormones produced by each
cell type.
It was therefore concluded that the antidiabetic effect of
Ba aqueous leaf extract is largely dependent on its ability
to modulate the production of inflammatory cytokines and
influence the proliferation, and possibly the function, of
pancreatic islet. The apparent recovery of islet sections
observed in this study offers future hope for an alternative
to pancreas/islet transplantation.
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